DJIA 16,924.80 5.21 0.03%
NASDAQ 4,517.30 -10.22 -0.23%
S&P 500 1,982.14 0.54 0.03%
market minute promo

2.49 -0.16 (-6.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $2.49 -6.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.45
Previous Close $2.65
Daily Range $2.35 - $2.56
52-Week Range $2.35 - $5.60
Market Cap $233.2M
P/E Ratio 9.81
Dividend (Yield) $0.00 (0.0%)
Volume 764,976
Average Daily Volume 353,982
Current FY EPS -$0.20

Sector

Healthcare

Industry

Drugs

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

Stocks Hitting 52-Week Lows

Protalix Biotherapeutics Reports New Data on ELELYSO, Oral GCD Will Be Presented at European Working

Protalix Biotherapeutics Reports New Data on ELELYSO, Oral GCD Will Be Presented at European Working Group on Gaucher Disease

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog

Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape

Sector Update: Healthcare Shares Flat Pre-Market; Cytori Down 1% on Plans to Sell 4 Mln Units

Relative Strength Alert For Protalix BioTherapeutics

Protalix Announces Data on Oral antiTNF to be Presented at Digestive Disease Week 2014 Meeting

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade

Sector Update: Healthcare

Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology

See More PLX News...

PLX's Top Competitors

PLX $2.49 (-6.04%)
Current stock: PLX
AMGN $132.54 (-0.36%)
Current stock: AMGN
GILD $101.26 (-0.02%)
Current stock: GILD
BIIB $342.08 (-1.09%)
Current stock: BIIB